Notus Mucus Sabor Limón (Acetylcysteine)

Acetylcysteine works by breaking disulfide bonds within mucin glycoproteins, which are the structural components of mucus. This chemical reduction disrupts the mucus network, lowering its viscosity and elasticity, so that ciliary movement and coughing can more effectively clear the secretions from the airways.

The specific dose of Notus Mucus Sabor Limón is determined by the prescribing healthcare professional based on the patient’s age, condition severity, and overall health status. Dosage instructions are provided on the prescription label and should be followed exactly as directed by the prescriber.

Safety data for acetylcysteine in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Healthcare providers should evaluate each case individually and discuss any concerns with the patient.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request trade or institutional credentials. The sales team will then respond with pricing, availability, shipping details and any necessary import documentation.

Acetylcysteine is a mucolytic that chemically reduces mucus viscosity, whereas many other expectorants, such as guaifenesin, act primarily by increasing airway fluid to loosen secretions. Acetylcysteine’s direct action on disulfide bonds can be more effective for thick, tenacious mucus, especially in chronic lung diseases.

The product should be stored at temperatures below 25 °C, in its original packaging, and protected from moisture and direct sunlight. Ensure the container is tightly closed after each use to maintain product stability and potency.

Notus Mucus Sabor Limón is an oral solution taken by mouth. The prescribed dose is measured using a calibrated device such as a syringe or dosing cup, and the solution is swallowed directly. It should be taken exactly as directed by the prescribing clinician.

Serious risks include allergic reactions such as rash, urticaria, or anaphylaxis, and bronchospasm, particularly in patients with asthma or reactive airway disease. Rarely, severe hypotension can occur when combined with nitrates. Patients should seek immediate medical attention if any of these symptoms develop.

Individuals with known hypersensitivity to acetylcysteine or any component of the formulation should avoid using the product. Patients with uncontrolled asthma, severe bronchospasm, or those taking nitrates without medical supervision should also be evaluated carefully before use.